Related Experiment Video

Updated: Jun 6, 2026

Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

CC3/TIP30 regulates metabolic adaptation of tumor cells to glucose limitation

Vivian Chen1, Emma Shtivelman

  • 1BioNovo, Inc., Emeryville, CA, USA.

Cell Cycle (Georgetown, Tex.)
|December 15, 2010
PubMed

Insights

CC3/TIP30, a tumor suppressor, enhances cancer cell survival under glucose limitation by improving metabolic adaptation, not by increasing apoptosis resistance. Silencing CC3 boosts mitochondrial respiration and glycolysis, aiding tumor growth in low-glucose environments.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Metabolism

Background:

  • CC3/TIP30 functions as a metastasis and tumor suppressor, often underexpressed in aggressive cancers.
  • While CC3 overexpression sensitizes cells to apoptosis, its absence doesn't confer general apoptotic resistance.

Purpose of the Study:

  • To investigate the role of CC3/TIP30 in cellular adaptation to glucose limitation.
  • To elucidate the metabolic mechanisms underlying CC3/TIP30's influence on tumor cell survival.

Main Methods:

  • CC3/TIP30 expression was silenced in HeLa cells using siRNA.
  • Cellular responses to glucose limitation were assessed, including apoptosis, mitochondrial respiration, glycolysis, and AMPK activation.
  • Quantitative analysis of mitochondrial proteins, c-MYC, and pyruvate kinase M2 was performed.

Main Results:

  • Silencing CC3/TIP30 significantly enhanced HeLa cell survival and metabolic adaptation during prolonged glucose deprivation.
  • CC3/TIP30-silenced cells exhibited elevated mitochondrial respiration and glycolysis, with increased expression of respiratory complex proteins, c-MYC, and pyruvate kinase M2.
  • These cells showed impaired AMPK activation, and AMPK inhibition protected control cells from glucose-limited death.

Conclusions:

  • CC3/TIP30 deficiency confers metabolic flexibility, promoting tumor cell survival in low-glucose conditions through enhanced mitochondrial respiration and glycolysis.
  • The findings suggest that CC3/TIP30's role in metabolic adaptation is crucial for aggressive tumor development and may represent a therapeutic target.

More Related Videos

Assessment of the Metabolic Profile of Primary Leukemia Cells06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...